FIDELITY NATIONAL FINANCIAL, INC. (FNF): what the price requires

At today's price, FIDELITY NATIONAL FINANCIAL, INC. (FNF) is priced for 14.5% return on equity. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high.

Generated: 2026-07-19 · Source: https://boothcheck.com/report/FNF

Headline

FieldValue
TickerFNF
CompanyFIDELITY NATIONAL FINANCIAL, INC.
Current price$50.17/sh
CompositionTitle 60% / F&G 40%

What The Price Requires (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basisfinancials
Return on equity needed14.5%
Return on equity now8.1%
ROE gap+6.4pp
Price-to-book1.86x

Solve inputs: computed at a 9.6% cost of equity with 4% terminal growth over a 5-year stage, on common book equity (FY2026); each 1pp of cost of equity moves the implied ROE ~1.9pp.

How unusual the bet is: within-range

ReferenceValue
vs own history+0.40σ
cohort percentile (of 80 peers)49
sustained it ~10 years at this level62%
implied end-window share0%

Valuation X-Ray

The price is supported by earnings-power and relative-multiple and growth-DCF value, while asset-based lands below the price. A value/asset-supported name, not a pure growth bet.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset1.54x3expensive
Earnings1.14x2expensive
Relative0.66x3justifies
Growth0.72x2justifies

Families that justify the price: Earnings, Relative, Growth Families that call it expensive: Asset

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 8.0%); the inversion above states its own rate.

Per-Model Detail (n=10)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth——no—
Bank Fair Value (P/TBV)—$9.145.49xyesTBVPS $7.58 × 1.21x (ROE (TTM) 10.5% / CoE 9.3%, g=5.0% (sustainable: 65% retention × ROE, 5% cap; not the terminal-growth assumption), credit 1.15% allowance/loans → ×0.93)
Relative ValuationRelative$37.311.34xyesP/E 13.01x (blended: static sector reference 11x + trailing (TTM) 18x), scenarios: 10.7x / 13.0x / 15.3x (bear / base = reference held flat / bull), EV/EBITDA 12.36x
Simple DDMGrowth——no—
Two-Stage DDMGrowth$73.830.68xyesStage 1: 20% for 5yr, Stage 2: 3.5% perpetual
Simple Excess ReturnAsset$30.621.64xyesBV/sh $26.97, ROE (TTM) 10.5%, ke 9.3%
Two-Stage Excess ReturnAsset$32.571.54xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$66.210.76xyesRev $14.9B, growth 14% (input: historical growth; tapered), Terminal P/S: 0.7x / 0.9x / 1.1x (bear / base = today's held flat / bull, cap 12x)
Peter Lynch Fair ValueRelative$76.080.66xyesEPS $2.73, growth 28% (input: historical EPS growth), PEG=0.63 (Undervalued)
Margin TrajectoryGrowth——no—
Earnings Power ValueEarnings——no—
Residual IncomeAsset——no—
Graham NumberAsset$40.671.23xyes√(22.5 × EPS $2.73 × BVPS $26.97) — Graham's conservative floor
EV/EBITDA RelativeRelative——no—
FCF YieldEarnings——no—
SBC-Adj FCF YieldEarnings——no—
Ben Graham FormulaEarnings$87.960.57xyesEPS $2.73 × (8.5 + 2×15.0%) × (4.4 / 5.3%)
ROIC-Justified P/BAsset——no—
P/Sales SectorRelative——no—
PEG Fair ValueRelative$102.230.49xyesEPS $2.73 × (PEG 1.5 × growth 25.0% (input: historical EPS growth)) → PE 37.5x
Earnings YieldEarnings$29.471.70xyesEPS $2.73 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelative——no—
Clinical Phase NPVGrowth——no—
MertonAsset——no—
V5 Mechanical———no—

Solvency

FieldValue
Share count CAGR (buyback)-3.1%

Deposit/float-funded balance sheet: debt is funding, not corporate leverage, and GAAP operating cash flow follows loan flows. Net-debt, interest-coverage, and cash-burn lenses do not apply. The solvency frame for a financial is regulatory capital and payout capacity (CET1, stress buffer, dividends plus buybacks against earnings).

Bullet Takeaways

Capital allocation defines Fidelity National Financial. The company pays a $0.52 quarterly dividend, roughly a 4% yield, buys back stock, and returned about $222 million to shareholders in a single quarter, all funded by a market-leading title-insurance franchise plus a majority stake in the growing F&G annuities business.

The price near $46.85 is read off price-to-book, as it should be for an insurer, at about 1.7 times book. That implies a sustained return on equity around 14%, above the roughly 8% earned recently but within reach of the company's longer-run average, which is why the priced-in assumption reads as within range rather than a stretch.

The bet is on the title cycle turning. Title order volumes track housing and refinancing, and a refinance surge already lifted orders and pushed the title margin to an industry-leading 13.1%. The risk is that title is cyclical, and a setback in rates or housing would pull the return back down.

Bull Case

The clearest lens on Fidelity National Financial is capital allocation, because this is a business built to generate and return cash. FNF runs the largest title-insurance operation in the country, a high-margin, capital-light business, alongside a majority interest in F&G, a fast-growing annuities and life insurer. The company pays a quarterly dividend of $0.52, a yield around 4%, supplements it with buybacks, and returned roughly $222 million to shareholders in the first quarter of 2026 while keeping about $495 million of cash at the holding company. A management team that pays a substantial, well-covered dividend and repurchases shares is signaling confidence in the durability of the cash flows behind them.

The earnings are inflecting as the title cycle turns. In the first quarter of 2026 net earnings attributable to common shareholders jumped to $243 million, or $0.90 a share, from $0.30 a year earlier, and adjusted earnings rose to $0.93 from $0.78. The title segment delivered $2.0 billion of revenue at an industry-leading adjusted pre-tax margin of 13.1%, up 140 basis points year over year, as closed order volume rose 16% and, notably, refinance orders opened up more than 50%. Title is the kind of operating-leverage business where a modest pickup in volume drops disproportionately to margin, so the early-cycle turn is powerful.

F&G is the second engine and a real source of value. It produced record assets under management before reinsurance of $74.5 billion, up about 11%, with gross sales of $3.2 billion on strong retirement-product demand, and it remains a meaningful contributor to FNF's adjusted earnings. The filing describes F&G's reach across "life customers and institutional clients" through its insurance subsidiaries [FY2025 10-K, accession 0001331875-26-000026], a spread-and-fee business that grows the asset base and the earnings alongside the title cycle. At about 1.7 times book, with a return on equity recovering toward its historical average near 13%, the price asks for a return the company has demonstrably earned before, which is why the priced-in assumption sits within range. The combination of a recovering title cycle, a growing F&G, and a generous capital-return program is the bull case.

Bear Case

The bear case is a sector-cycle case, and the central question is whether the title margin the price assumes is sustainable or a cyclical high. Title insurance is intensely tied to real-estate transaction volume, which is tied to mortgage rates and housing activity, all of which FNF cannot control. The filing is explicit that residential title volume "is primarily affected by macroeconomic and seasonal factors," while commercial title demand "varies based on a variety of factors such as investor appetite, financing availability and supply and demand" [FY2025 10-K, accession 0001331875-26-000026]. The first-quarter strength leaned heavily on a refinance surge, with refi orders up more than 50%, and refinance activity is the most rate-sensitive and volatile part of the mix. If mortgage rates back up, that refi tailwind reverses quickly, and the 13.1% title margin compresses toward the lower end of the cycle.

That cyclicality is why the implied return looks demanding against the recent trough. The price pays about 1.7 times book and implies a sustained return on equity around 14%, while the company has earned closer to 8% recently. The model treats 14% as within reach because it sits near the company's longer-run average, but averages span both peaks and troughs; paying a peak-of-cycle multiple of book for a return that requires the cycle to stay favorable is the risk. On tangible book the stock is not cheap.

The F&G side carries its own, different risks. As a spread-based annuity writer, F&G's profitability depends on the gap between what it earns on its investment portfolio and what it credits policyholders, which exposes it to credit losses and interest-rate movements. The filing notes that reserve development "periodically includes amounts of estimated adverse or positive development on prior years' policies" [FY2025 10-K, accession 0001331875-26-000026], the reminder that insurance earnings can be revised by reserve and claims experience. A credit cycle that hurts F&G's portfolio, layered on a title downturn, would pressure both engines at once. A cyclical insurer at 1.7 times book with an above-trough implied return has limited cushion if either cycle turns.

Valuation

Fidelity National Financial is valued the way an insurer should be, off the price you pay for its book value rather than an operating multiple, because an insurer is worth the return it earns on its capital. At about $46.85 (June 27, 2026) the stock trades at roughly 1.7 times book value of $26.97 a share, which sits in the upper half of its peer group. Read backward, that price implies the company sustains a return on equity around 14%, against the roughly 8% it has earned recently. The key is that 14% is within reach of FNF's longer-run average near 13%, so the framework reads the priced-in assumption as within range rather than a stretch, even though it sits above the current trough return.

The X-ray brackets the price and tilts toward support. The relative method on a blended earnings multiple lands near $36, the asset-based excess-return frames land in the low $30s, and the discounted-future-market-cap frame lands near $49, close to the price. The growth-oriented frames, the two-stage dividend-discount and PEG models, land well above the price on the company's strong recent earnings growth. The characterization is that earnings-power, relative-multiple, and growth value support the price, an asset-and-earnings-supported name rather than a pure growth bet.

The honest synthesis is that the valuation is fair if you believe the title cycle holds and F&G keeps growing. The implied return is achievable for this franchise, the dividend and buybacks add to the total return, and the F&G stake is a genuine source of value the simplest title comps miss. The risk is the cyclicality: the price pays a premium to book that assumes an above-trough return, so a title downturn or an F&G credit setback would pull the return toward the level where the conservative methods sit below the price.

Catalysts

The most recent catalyst was the first-quarter 2026 report, which showed a strong year-over-year earnings recovery even as it missed elevated estimates. FNF reported total revenue of $3.226 billion and net earnings attributable to common shareholders of $243 million, or $0.90 a share, up sharply from $0.30 a year earlier, with adjusted earnings of $0.93. The title segment delivered an industry-leading 13.1% adjusted pre-tax margin on $2.0 billion of revenue, closed orders rose 16%, and refinance orders opened up more than 50%. Earnings of $0.93 fell short of the roughly $1.09 consensus and revenue missed as well, which is the cautionary note in an otherwise improving quarter.

The capital-return program is a steady catalyst. FNF reaffirmed its $0.52 quarterly dividend and returned about $222 million to shareholders through dividends and buybacks in the quarter, ending with $495 million of holding-company cash, so continued dividends and repurchases are dependable drivers, and any dividend increase would be a positive signal.

The macro swing factor is the title cycle. Mortgage rates and housing-transaction volume drive title order counts and margins, so the path of rates is the single biggest external variable; a continued refinance recovery would extend the margin gains, while a rate back-up would reverse them. On the F&G side, the pace of annuity sales, the growth in assets under management, and the credit performance of its investment portfolio are the metrics to watch, with F&G having posted record AUM of $74.5 billion. Governance is a minor catalyst, with the company phasing out its classified board structure.

Sources: FNF Q1 2026 results, FNF IR; FNF Q1 2026 profit rises, title margin 13.1%, StockTitan; FNF Q1 2026 earnings jump, margins, StockTitan; FNF Q1 earnings and revenue lag estimates, Yahoo Finance; FNF Q1 2026 8-K press release, SEC.

Peer Cohorts (Per Segment, With Filing Citations)

Title (reported)

F&G (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

View the full interactive FNF report on boothcheck